Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Immunobiology ; 227(6): 152284, 2022 11.
Article in English | MEDLINE | ID: mdl-36191584

ABSTRACT

Asthma is a disorder characterized by airflow obstruction, inflammation, declining airway function, bronchial hyperresponsiveness and tissue remodelling. Probiotics are defined as "live microorganisms that, when administered in adequate amounts, confer a health benefit on the host". The use of probiotics is becoming increasingly studied and recent evidence has suggested that it may provide therapeutic benefits in asthma and other diseases. Lactobacillus delbrueckii UFV-H2b20 fulfils all the requirements to be classified as probiotic. Previous studies have already shown the ability of L. delbrueckii UFV-H2b20 to stimulate the immune system. Our objective was to evaluate the protective effects of L. delbrueckii UFV-H2b20 in experimental allergic asthma. We used a murine model of ovalbumin-induced allergic airway inflammation to mimic allergic asthma. Oral treatment with L. delbrueckii UFV-H2b20 improves respiratory parameters and inhibits the inflammatory response in the lungs by decreasing the numbers of inflammatory monocytes, eosinophils and alveolar macrophages, as well as IgE levels. Treatment increased the IFN-γ/IL-4 cytokine ratio. Levels of IL-10 in the lungs were also increased in treated animals. Our results also showed that the probiotic administration increases the number of CD39+CD73+ T regulatory lymphocytes in the lung, suggesting a role for purinergic signals in the regulation of inflammation promoted by the treatment. Understanding the mechanisms of modulation of the immune system by probiotics could allow the development of probiotic preparations that are safe and have a direct action. Our results suggest that oral administration of L. delbrueckii UFV-H2b20 could be helpful to treat chronic inflammatory airway diseases, such as asthma.


Subject(s)
Asthma , Lactobacillus delbrueckii , Probiotics , Animals , Mice , Asthma/therapy , Bronchoalveolar Lavage Fluid , Cell Count , Cytokines/pharmacology , Disease Models, Animal , Inflammation , Interferon-gamma/metabolism , Lactobacillus delbrueckii/physiology , Lung , Mice, Inbred BALB C , Ovalbumin , T-Lymphocytes, Regulatory
2.
Cytokine ; 147: 155309, 2021 11.
Article in English | MEDLINE | ID: mdl-33334669

ABSTRACT

Macrophages are host cells for parasites of the genus Leishmania where they multiply inside parasitophorous vacuoles. Paradoxically, macrophages are also the cells responsible for killing or controlling parasite growth, if appropriately activated. In this review, we will cover the patterns of macrophage activation and the mechanisms used by the parasite to circumvent being killed. We will highlight the impacts of the vector bite on macrophage activation. Finally, we will discuss the ontogeny of macrophages that are infected by Leishmania spp.


Subject(s)
Cytokines/metabolism , Leishmaniasis/metabolism , Leishmaniasis/parasitology , Macrophages/metabolism , Macrophages/parasitology , Animals , Humans , Leishmania/pathogenicity , Macrophage Activation/physiology
3.
Vet Parasitol ; 166(3-4): 333-9, 2009 Dec 23.
Article in English | MEDLINE | ID: mdl-19811877

ABSTRACT

Ten-month-old calves Bos taurus taurus were immunized with three doses of SBm7462 with saponin as an adjuvant at 30-day intervals and were evaluated for IgG isotypes, phenotype circulating lymphocytes and changes in the lymph nodes (LN). SBm7462 stimulated the production of predominantly IgG1-isotype IgG antibodies. The lymph nodes exhibited activation at the seventh day after the first immunization, with areas of paracortical and interfollicular hyperplasia and the early formation of germinal centers (GC). Fifteen days after the first immunization, the GC exhibited compartmentalization of cellular populations, a light zone (LZ), a dark zone (DZ) and a mantle. At the same time, hyperplasia of the medullary cords was observed with cells associating with DC cells. Seven days after the first immunization, apoptosis in the DZ and in the paracortical region became evident. By day 15, there was an increase in the medullary cords, which became more numerous at days 35 and 42. PAP-positive cells were found in the paracortical region, medullary cords and GC 7 days after the first immunization. At day 35, there were further strongly PAP-positive cells in the medullary cords. By comparison, none of these changes were observed in the lymph nodes of control groups at any of the days analyzed. The number of CD21(+) lymphocytes increased in the immunized groups after the first inoculation, with a maximum number observed at 15 and 10 days after the first and third immunizations, respectively. Compared to pre-immunization counts, the percentage of WC1(+) gammadelta T-lymphocytes displayed more variation, increasing 5 days after the second immunization but decreasing over the following days. According to the results, the synthetic anti Rhipicephalus microplus vaccine elicits a complete immune response being T-dependant.


Subject(s)
Cattle Diseases/prevention & control , Rhipicephalus/immunology , Tick Infestations/veterinary , Vaccines, Synthetic/immunology , Animals , Cattle , Cattle Diseases/parasitology , Immunoglobulin G/blood , Leukocytes, Mononuclear/immunology , Lymph Nodes/immunology , Random Allocation , Tick Infestations/prevention & control
4.
Braz. j. med. biol. res ; 42(4): 358-367, Apr. 2009. graf
Article in English | LILACS | ID: lil-509175

ABSTRACT

Lactobacillus delbrueckii UFV-H2b20 has been shown to increase clearance of bacteria injected into the blood of germ-free mice. Moreover, it induces the production of type 1 cytokines by human peripheral mononuclear cells. The objective of the present study was to investigate the production of inflammatory cytokines [interleukin-12 (IL-12 p40), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ)] triggered in vitro by live, heat-killed or lysozyme-treated L. delbrueckii UFV-H2b20 and in vivo by a live preparation. Germ-free, L. delbrueckii-monoassociated and lipopolysaccharide (LPS)-resistant C3H/HeJ mice were used as experimental models. UFV-H2b20 induced the production of IL-12 p40 and TNF-α by peritoneal cells and IFN-γ by spleen cells from germ-free or monoassociated Swiss/NIH mice and LPS-hyporesponsive mice (around 40 ng/mL for IL-12 p40, 200 pg/mL for TNF-α and 10 ng/mL for IFN-γ). Heat treatment of L. delbrueckii did not affect the production of these cytokines. Lysozyme treatment decreased IL-12 p40 production by peritoneal cells from C3H/HeJ mice, but did not affect TNF-α production by these cells or IFN-γ production by spleen cells from the same mouse strain. TNF-α production by peritoneal cells from Swiss/NIH L. delbrueckii-monoassociated mice was inhibited by lysozyme treatment. When testing IL-12 p40 and IFN-γ levels in sera from germ-free or monoassociated Swiss/NIH mice systemically challenged with Escherichia coli we observed that IL-12 p40 was produced at marginally higher levels by monoassociated mice than by germ-free mice (40 vs 60 ng/mL), but IFN-γ was produced earlier and at higher levels by monoassociated mice (monoassociated 4 and 14 ng/mL 4 and 8 h after infection, germfree 0 and 7.5 ng/mL at the same times). These results show that L. delbrueckii UFV-H2b20 stimulates the production of type 1 cytokines in vitro and in vivo, therefore suggesting...


Subject(s)
Animals , Mice , Interferon-gamma/biosynthesis , /biosynthesis , Lactobacillus delbrueckii/immunology , Macrophages, Peritoneal/immunology , Tumor Necrosis Factor-alpha/biosynthesis , Escherichia coli/immunology , Germ-Free Life/immunology , Macrophages, Peritoneal/microbiology
5.
Braz J Med Biol Res ; 42(4): 358-67, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19330264

ABSTRACT

Lactobacillus delbrueckii UFV-H2b20 has been shown to increase clearance of bacteria injected into the blood of germ-free mice. Moreover, it induces the production of type 1 cytokines by human peripheral mononuclear cells. The objective of the present study was to investigate the production of inflammatory cytokines [interleukin-12 (IL-12 p40), tumor necrosis factor-alpha (TNF-alpha), and interferon-gamma (IFN-gamma)] triggered in vitro by live, heat-killed or lysozyme-treated L. delbrueckii UFV-H2b20 and in vivo by a live preparation. Germ-free, L. delbrueckii-monoassociated and lipopolysaccharide (LPS)-resistant C3H/HeJ mice were used as experimental models. UFV-H2b20 induced the production of IL-12 p40 and TNF-alpha by peritoneal cells and IFN-gamma by spleen cells from germ-free or monoassociated Swiss/NIH mice and LPS-hyporesponsive mice (around 40 ng/mL for IL-12 p40, 200 pg/mL for TNF-alpha and 10 ng/mL for IFN-gamma). Heat treatment of L. delbrueckii did not affect the production of these cytokines. Lysozyme treatment decreased IL-12 p40 production by peritoneal cells from C3H/HeJ mice, but did not affect TNF-alpha production by these cells or IFN-gamma production by spleen cells from the same mouse strain. TNF-alpha production by peritoneal cells from Swiss/NIH L. delbrueckii-monoassociated mice was inhibited by lysozyme treatment. When testing IL-12 p40 and IFN-gamma levels in sera from germ-free or monoassociated Swiss/NIH mice systemically challenged with Escherichia coli we observed that IL-12 p40 was produced at marginally higher levels by monoassociated mice than by germ-free mice (40 vs 60 ng/mL), but IFN-gamma was produced earlier and at higher levels by monoassociated mice (monoassociated 4 and 14 ng/mL 4 and 8 h after infection, germfree 0 and 7.5 ng/mL at the same times). These results show that L. delbrueckii UFV-H2b20 stimulates the production of type 1 cytokines in vitro and in vivo, therefore suggesting that L. delbrueckii might have adjuvant properties in infection in which these cytokines play a major role.


Subject(s)
Interferon-gamma/biosynthesis , Interleukin-12/biosynthesis , Lactobacillus delbrueckii/immunology , Macrophages, Peritoneal/immunology , Tumor Necrosis Factor-alpha/biosynthesis , Animals , Escherichia coli/immunology , Germ-Free Life/immunology , Macrophages, Peritoneal/microbiology , Mice , Mice, Inbred C3H
6.
Acta Trop ; 106(1): 27-38, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18313021

ABSTRACT

Experimental models of infection with Leishmania spp. have provided knowledge of several immunological events involved in the resistance mechanism used by the host to restrain parasite growth. It is well accepted that concomitant immunity exists, and there is some evidence that it would play a major role in long-lasting acquired resistance to infection. In this paper, the resistance to Leishmania amazonensis infection in C57BL/6 mice infected with Leishmania major was investigated. C57BL/6 mice, which spontaneously heal lesions caused by infection with L. major, were infected with L. amazonensis at different times before and after L. major. We demonstrated that C57BL/6 mice previously infected with L. major restrain pathogenic responses induced by L. amazonensis infection and decrease parasite burdens by one order of magnitude. Co-infected mice showed production of IFN-gamma in lesions similar to mice infected solely with L. major, but higher TNF-alpha and nitric oxide synthase (iNOS) mRNA expression was observed. Surprisingly, the restrained pathogenic response was not related to IL-10 production, as evidenced by lower levels of both mRNA, protein expression in lesions from co-infected mice and in co-infections in IL-10(-/-) mice. Examination of the inflammatory infiltrate at the site of infection showed a reduced number of monocytes and lymphocytes in L. amazonensis lesions. Additionally, differential production of the CCL3/MIP-1 alpha and CCL5/RANTES was observed. We suggest that the control of lesion progression caused by L. amazonensis in C57BL/6 mice pre-infected with L. major is related to the induction of a down-regulatory environment at the site of infection with L. amazonensis.


Subject(s)
Leishmania major/immunology , Leishmania/immunology , Leishmaniasis/immunology , Animals , Chemokine CCL3/biosynthesis , Chemokine CCL5/biosynthesis , Female , Foot/pathology , Interferon-gamma/biosynthesis , Interleukin-10/deficiency , Interleukin-10/immunology , Leishmaniasis/parasitology , Leishmaniasis/pathology , Lymphocytes/immunology , Mice , Mice, Inbred C57BL , Mice, Knockout , Monocytes/immunology , Nitric Oxide Synthase/biosynthesis , Tumor Necrosis Factor-alpha/biosynthesis
7.
Parasitology ; 131(Pt 4): 477-88, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16174412

ABSTRACT

In order to investigate the importance of the host microbiota on differentiation of T cell subsets in response to infection, Swiss/NIH germ-free mice and conventional (microbiota-bearing) mice were infected with Leishmania major, and lesion development, parasite loads, and cytokine production were assessed. Germ-free mice failed to heal lesions and presented a higher number of parasites at the site of infection than their conventional counterparts. In addition, histopathological analysis indicated a higher density of parasitized macrophages in lesions from germ-free mice than in conventional mice. The initial production of interleukin (IL)-12 and interferon-gamma (IFN-gamma) in germ-free mice was comparable to the conventional controls. Also, germ-free mice produced elevated levels of IFN-gamma and lower levels of IL-4 throughout the course of infection, suggesting the development of a Th1 response. Macrophages from germ-free mice exposed to IFN-gamma and infected with amastigotes in vitro were not as efficient at killing parasites as macrophages from conventional animals. These observations indicate that the microbiota is not essential for the development of Th1 immune responses, but seems to be important for macrophage activation.


Subject(s)
Cytokines/biosynthesis , Interferon-gamma/biosynthesis , Leishmania major , Leishmaniasis, Cutaneous/pathology , Th1 Cells/microbiology , Animals , Cell Culture Techniques , Cytokines/analysis , Disease Models, Animal , Female , Germ-Free Life , Interferon-gamma/analysis , Leishmaniasis, Cutaneous/immunology , Leishmaniasis, Cutaneous/microbiology , Macrophage Activation/immunology , Mice , Th1 Cells/immunology
8.
Exp Parasitol ; 111(2): 87-96, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16038901

ABSTRACT

To verify the influence of some predominant components from indigenous microbiota on systemic immunological responses during experimental Chagas disease, germ-free NIH Swiss mice were mono-associated with Escherichia coli, Enterococcus faecalis, Bacteroides vulgatus or Peptostreptococcus sp. and then infected with the Y strain of Trypanosoma cruzi. All the mono-associations predominantly induced a Th1 type of specific immune response to the infection by T. cruzi. A direct correlation was observed between a higher survival rate and increased IFN-gamma and TNF-alpha production (P<0.05) in E. faecalis-, B. vulgatus-, and Peptostreptococcus-associated mice. Moreover, higher levels of anti-T. cruzi IgG1 and anti-T. cruzi IgG2a were also found in mono-associated animals after infection. On the other hand, with the exception of E. faecalis-associated mice, mono-association induced a lower IL-10 production after infection (P<0.05) when compared with germ-free animals. Interestingly, spleen cell cultures from non-infected germ-free and mono-associated mice spontaneously produced higher levels (P<0.05) of IL-10 than cultures from infected mono-associated mice, except again for E. faecalis-associated animals. In conclusion, the presence of the components of the indigenous microbiota skews the immune response towards production of inflammatory cytokines during experimental infection with T. cruzi in gnotobiotic mice. However, the degree of increase in production of cytokines depends on each bacterial component.


Subject(s)
Chagas Disease/immunology , Feces/microbiology , Gram-Negative Bacteria/physiology , Gram-Positive Bacteria/physiology , Animals , Bacteroides/physiology , Cells, Cultured , Chagas Disease/mortality , Cytokines/biosynthesis , Enterococcus faecalis/physiology , Escherichia coli/physiology , Female , Germ-Free Life , Humans , Immunoglobulin G/blood , Male , Mice , Nitric Oxide/biosynthesis , Peptostreptococcus/physiology , Spleen/cytology , Spleen/immunology , Survival Rate , Trypanosoma cruzi/immunology
9.
Mem. Inst. Oswaldo Cruz ; 96(1): 89-98, Jan. 2001. ilus, tab
Article in English | LILACS | ID: lil-281634

ABSTRACT

In this study, we evaluated the immune response of patients suffering from cutaneous leishmaniasis treated with two distinct protocols. One group was treated with conventional chemotherapy using pentavalent antimonium salts and the other with immunochemotherapy where a vaccine against cutaneous leishmaniasis was combined with the antimonium salt. Our results show that, although no differences were observed in the necessary time for complete healing of the lesions between the two treatments, peripheral blood mononuclear cells from patients treated by chemotherapy showed smaller lymphoproliferative responses at the end of the treatment than those from patients in the immunochemotherapy group. Furthermore, IFN-gamma production was also different between the two groups. While cells from patients in the chemotherapy group produced more IFN-gamma at the end of treatment, a significant decrease in this cytokine production was associated with healing in the immunochemotherapy group. In addition, IL-10 production was also less intense in this latter group. Finally, an increase in CD8+ -IFN-gamma producing cells was detected in the chemotherapy group. Together these results point to an alternative treatment protocol where healing can be induced with a decreased production of a potentially toxic cytokine


Subject(s)
Humans , Male , Female , Adult , Antiprotozoal Agents/therapeutic use , Interferon-gamma/biosynthesis , Leishmaniasis, Cutaneous/drug therapy , Leishmania/immunology , Protozoan Vaccines/therapeutic use , Antigens, Protozoan/immunology , Antimony/therapeutic use , Cytokines/biosynthesis , Double-Blind Method , Drug Therapy, Combination , Enzyme-Linked Immunosorbent Assay , Interleukin-10/biosynthesis
10.
Rev. Inst. Med. Trop. Säo Paulo ; 40(6): 355-62, Nov.-Dec. 1998. ilus, tab
Article in English | LILACS | ID: lil-228036

ABSTRACT

Camundongos isentos de germes (GF) e convencionais (CV) foram alimentados com racoes contendo 4,4, 13,2 ou 26,4 por cento de proteina nao ganharam peso durante quatro semanas, enquanto a racao deficiente em proteina nao afetou o crescimento dos camundongos GF. Apos quatro semanas nessas racoes, os camundongos foram inoculados com 5x10 elevado ao cubo tripomastigotos de Trypanosoma cruzi. A deficiencia em proteina afetou menos os camundongos GF do que os CV, segundo os seguintes parametros: ganho em peso, hemoglobina, niveis em proteina e albumina no plasma e conteudos em agua e proteina na carcassa. A infeccao com T. cruzi produziu um decrescimo significante nos niveis em hemoglobina, na contagem de celulas vermelhas sanguineas e nos conteudos em agua e proteina na carcaca. Este decrescimo foi mais acentuado nos camundongos GF...


Subject(s)
Animals , Male , Mice , Chagas Disease/diet therapy , Dietary Proteins/therapeutic use , Trypanosoma cruzi/isolation & purification , Trypanosoma cruzi/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...